Follow
Lior Nissim (ליאור ניסים)
Lior Nissim (ליאור ניסים)
The Hebrew University-Hadassah Medical School Jerusalem
Verified email at ekmd.huji.ac.il - Homepage
Title
Cited by
Cited by
Year
Multiplexed and programmable regulation of gene networks with an integrated RNA and CRISPR/Cas toolkit in human cells
L Nissim, SD Perli, A Fridkin, P Perez-Pinera, TK Lu
Molecular cell 54 (4), 698-710, 2014
4922014
A tunable dual‐promoter integrator for targeting of cancer cells
L Nissim, RH Bar‐Ziv
Molecular systems biology 6 (1), 444, 2010
1622010
Synthetic RNA-based immunomodulatory gene circuits for cancer immunotherapy
L Nissim, MR Wu, E Pery, A Binder-Nissim, HI Suzuki, D Stupp, ...
Cell 171 (5), 1138-1150. e15, 2017
1462017
Methods and compositions for the production of guide rna
TKT Lu, L Nissim, SD Perli
US Patent App. 15/301,135, 2017
1062017
A high-throughput screening and computation platform for identifying synthetic promoters with enhanced cell-state specificity (SPECS)
MR Wu, L Nissim, D Stupp, E Pery, A Binder-Nissim, K Weisinger, ...
Nature communications 10 (1), 2880, 2019
592019
The onset of p53-dependent apoptosis plays a role in terminal differentiation of human normoblasts
S Peller, J Frenkel, T Lapidot, J Kahn, N Rahimi-Levene, R Yona, ...
Oncogene 22 (30), 4648-4655, 2003
382003
p53 is a regulator of macrophage differentiation
D Matas, M Milyavsky, I Shats, L Nissim, N Goldfinger, V Rotter
Cell Death & Differentiation 11 (4), 458-467, 2004
312004
Cellular heterogeneity mediates inherent sensitivity–specificity tradeoff in cancer targeting by synthetic circuits
M Morel, R Shtrahman, V Rotter, L Nissim, RH Bar-Ziv
Proceedings of the National Academy of Sciences 113 (29), 8133-8138, 2016
272016
An autonomous system for identifying and governing a cell's state in yeast
L Nissim, T Beatus, R Bar-Ziv
Physical biology 4 (3), 154, 2007
162007
Contact guidance and collective migration in the advancing epithelial monolayer
G Lee, L Atia, B Lan, Y Sharma, L Nissim, MR Wu, E Pery, TK Lu, CY Park, ...
Connective tissue research 59 (4), 309-315, 2018
112018
Synthetic gene circuits
B Jusiak, R Daniel, F Farzadfard, L Nissim, O Purcell, J Rubens, TK Lu
Synthetic Biology, 2 Volumes, 249, 2015
82015
Synthetic circuit-driven expression of heterologous enzymes for disease detection
J He, L Nissim, AP Soleimany, A Binder-Nissim, HE Fleming, TK Lu, ...
ACS Synthetic Biology 10 (9), 2231-2242, 2021
62021
Modeling SARS-CoV-2 Infection in Mice Using Lentiviral hACE2 Vectors Infers Two Modes of Immune Responses to SARS-CoV-2 Infection
C Katzman, T Israely, S Melamed, B Politi, A Sittner, Y Yahalom-Ronen, ...
Viruses 14 (1), 11, 2021
22021
Tumor immunotherapy
TKT Lu, L Nissim, MR Wu
US Patent App. 15/737,829, 2019
22019
Genetic Modification of Tumor-Infiltrating Lymphocytes, Peripheral T Cells, and T-Cell Model Cell Lines
H Weinstein-Marom, D Blokon-Kogan, M Levi-Mann, C Katzman, ...
Cancer Immunotherapy: Methods and Protocols, 167-186, 2023
2023
Synthetic promoters
TKT Lu, L Nissim, MR Wu
US Patent 11,718,860, 2023
2023
Systems and uses thereof for creating synthetic transcriptional logic'and'gates based on pre-mrna trans-splicing
L Nissim, G Gross, H Weinstein-Marom, R Keren
2020
Tumor-Selective Gene Circuits Enable Highly Specific Localized Cancer Immunotherapy
MR Wu, L Nissim, E Pery, Y Tabach, PA Sharp, D Stupp, A Binder-Nissim, ...
MOLECULAR THERAPY 28 (4), 9-9, 2020
2020
Tumor immunotherapy
TKT Lu, L Nissim, MR Wu
2016
Methods and compositions for the production of guide rna
TKT Lu, L Nissim, SD PERLI
2015
The system can't perform the operation now. Try again later.
Articles 1–20